Overview

Vancomycin Prophylaxis in Recurrent Clostridium Difficile Infection

Status:
Unknown status
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
We are doing this research study to determine if taking vancomycin in addition to a broad-spectrum antibiotic will decrease the chance of developing recurrent Clostridium difficile infection.
Phase:
Phase 4
Details
Lead Sponsor:
Spectrum Health Hospitals
Treatments:
Vancomycin